Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Quantum Biopharma ( (TSE:QNTM) ) has provided an update.
On July 22, 2025, Quantum BioPharma announced a strategic investment in GameStop Corp. by purchasing 2,000 shares, aligning with its commitment to combat market corruption and enhance shareholder value. The company has been actively fighting market manipulation and has taken legal action against several financial institutions for alleged stock price manipulation. This investment in GameStop is part of Quantum BioPharma’s broader strategy to deploy capital into undervalued assets with strong fundamentals, while continuing to focus on its core mission of developing treatments for neurodegenerative disorders.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is advancing its lead compound, Lucid-MS, which targets multiple sclerosis by preventing and reversing myelin degradation. Quantum BioPharma also retains a strategic investment portfolio and has spun out its OTC product, unbuzzd, to Unbuzzd Wellness Inc., while maintaining a significant ownership stake.
Average Trading Volume: 7,423
Technical Sentiment Signal: Buy
Current Market Cap: C$93.04M
For an in-depth examination of QNTM stock, go to TipRanks’ Overview page.